Eric C. Olivares, Ph.D.
Affiliations: | 2003 | Stanford University, Palo Alto, CA |
Area:
Genetics, Molecular BiologyGoogle:
"Eric Olivares"Parents
Sign in to add mentor| Michele P. Calos | grad student | 2003 | Stanford | |
| (Phage integrases for gene therapy: From concept to application.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Keravala A, Lee S, Thyagarajan B, et al. (2009) Mutational derivatives of PhiC31 integrase with increased efficiency and specificity Molecular Therapy. 17: 112-120 |
| Chalberg TW, Portlock JL, Olivares EC, et al. (2006) Integration specificity of phage phiC31 integrase in the human genome. Journal of Molecular Biology. 357: 28-48 |
| Bertoni C, Jarrahian S, Wheeler TM, et al. (2006) Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proceedings of the National Academy of Sciences of the United States of America. 103: 419-24 |
| Keravala A, Lee S, Olivares EC, et al. (2006) 525. Mutants of phiC31 Integrase with Increased Efficiency and Specificity Molecular Therapy. 13: S201-S202 |
| Bertoni C, Jarrahian S, Wheeler TM, et al. (2006) 34. Phi C31 Integrase System Enhances Dystrophin Gene Expression in Skeletal Muscle of Mouse Models for Duchenne Muscular Dystrophy Molecular Therapy. 13: S14-S15 |
| Held PK, Olivares EC, Aguilar CP, et al. (2005) In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 399-408 |
| Held PK, Olivares EC, Aguilar CP, et al. (2005) In vivo correction of murine hereditary tyrosinemia type I by phiC31 integrase-mediated gene delivery. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 399-408 |
| Bertoni C, Jarrahian S, Wheeler TM, et al. (2005) 265. Enhanced Plasmid-Mediated Dystrophin Expression in the mdx Mouse Model for Duchenne Muscular Dystrophy by a PhiC31 Integrase Plasmid System Molecular Therapy. 11 |
| Portlock JL, Chalberg TW, Olivares EC, et al. (2005) 194. Characteristics of Site-Specific Integration as Mediated by PhiC31 Integrase in the Human Genome Molecular Therapy. 11 |
| Quenneville SP, Chapdelaine P, Rousseau J, et al. (2004) Nucleofection of muscle-derived stem cells and myoblasts with φC31 integrase: Stable expression of a full-length-dystrophin fusion gene by human myoblasts Molecular Therapy. 10: 679-687 |